Published in Arch Surg on July 01, 2006
Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis. World J Surg (2011) 0.85
Giant intrathyroidal parathyroid adenoma. J Emerg Trauma Shock (2012) 0.82
Primary hyperparathyroidism presenting as hypercalcemic crisis: Twenty-year experience. Indian J Endocrinol Metab (2015) 0.80
Management and surgical treatment of parathyroid crisis secondary to parathyroid tumors: report of four cases. Int Med Case Rep J (2011) 0.75
Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidism. J Surg Res (2017) 0.75
Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice. Int J Cancer (2002) 2.12
Surgeon-performed ultrasound can predict differentiated thyroid cancer in patients with solitary thyroid nodules. Ann Surg Oncol (2009) 2.09
Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery (2003) 2.03
Thyroid cancer: is the incidence still increasing? Ann Surg Oncol (2004) 1.82
Thyroidectomy remains an effective treatment option for Graves' disease. Am J Surg (2006) 1.67
Long-term outcome of patients with elevated parathyroid hormone levels after successful parathyroidectomy for sporadic primary hyperparathyroidism. Arch Surg (2008) 1.50
Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg (2004) 1.32
Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res (2002) 1.23
Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford) (2010) 1.17
Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol (2005) 1.16
Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. J Am Coll Surg (2011) 1.16
Surgical management of primary hyperparathyroidism: state of the art. Surg Clin North Am (2009) 1.06
Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg (2005) 1.03
Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg (2004) 1.01
Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg (2004) 1.00
Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies. Surgery (2008) 0.98
Resident education in 2011: three key challenges on the road ahead. Surgery (2011) 0.98
Surgeon-performed ultrasound: a single institution experience in parathyroid localization. Surgery (2009) 0.95
Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients. Arch Surg (2010) 0.93
Parathyroidectomy outcomes according to operative approach. Am J Surg (2007) 0.93
Developments in the use of ultrasound for thyroid cancer. Curr Opin Oncol (2010) 0.93
Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res (2008) 0.91
Adrenocorticotropic hormone-secreting pancreatic islet cell carcinoma. J Am Coll Surg (2004) 0.91
Rapid insulin assay for intraoperative confirmation of complete resection of insulinomas. Surgery (2002) 0.90
Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. Endocr Relat Cancer (2012) 0.90
New point-of-care intraoperative parathyroid hormone assay for intraoperative guidance in parathyroidectomy. World J Surg (2002) 0.89
Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J Am Coll Surg (2006) 0.89
Complete androgen insensitivity syndrome: the role of the endocrine surgeon. Am Surg (2005) 0.89
Toxic nodular goiter and cancer: a compelling case for thyroidectomy. Ann Surg Oncol (2012) 0.88
Is potassium iodide solution necessary before total thyroidectomy for Graves disease? Ann Surg Oncol (2013) 0.88
Consequences of parathyroidectomy in patients with "mild" sporadic primary hyperparathyroidism. Surgery (2007) 0.86
Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol (2014) 0.86
Use of ultrasound in the management of thyroid cancer. Oncologist (2010) 0.86
Impact of surgical mentorship on retroperitoneoscopic adrenalectomy with comparison to transperitoneal laparoscopic adrenalectomy. Am Surg (2013) 0.85
Pheochromocytoma presenting with multiple organ failure. Am Surg (2008) 0.84
A prospective evaluation of the effect of sample collection site on intraoperative parathormone monitoring during parathyroidectomy. Surgery (2008) 0.83
Surgeon-performed ultrasound improves localization of abnormal parathyroid glands. Am Surg (2005) 0.83
Metastatic choriocarcinoma to the pancreas. Am Surg (2005) 0.83
Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma? Cancer (2010) 0.83
Short-term outcomes of parathyroidectomy in patients with or without 25-hydroxy vitamin D insufficiency. J Surg Res (2007) 0.82
Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery (2007) 0.82
Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg (2004) 0.81
Same-day ultrasound guidance in reoperations for locally recurrent papillary thyroid cancer. Surgery (2007) 0.80
Normocalcemic parathormone elevation after successful parathyroidectomy: long-term analysis of parathormone variations over 10 years. Surgery (2011) 0.80
Expense of robotic thyroidectomy: a cost analysis at a single institution. Arch Surg (2012) 0.80
Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidism. Ann Surg Oncol (2014) 0.80
Mediastinal hyperfunctioning parathyroids: incidence, evolving treatment, and outcome. Am J Surg (2007) 0.80
Does histopathology predict parathyroid hypersecretion and influence correctly the extent of parathyroidectomy in patients with sporadic primary hyperparathyroidism? Surgery (2007) 0.79
Neurofibromatosis-associated pheochromocytoma. J Am Coll Surg (2005) 0.78
Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2. Horm Cancer (2015) 0.77
Lithium use and primary hyperparathyroidism. Endocr Pract (2011) 0.77
Long-term outcome of patients with intraoperative parathyroid level remaining above the normal range during parathyroidectomy. Surgery (2008) 0.77
Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism. Surgery (2002) 0.76
Primary hyperparathyroidism in the underinsured: a study of 493 patients. Surgery (2011) 0.76
Surgical management of primary hyperparathyroidism: the case for giving up quick intraoperative PTH assay in favor of routine measurement the morning after. Ann Surg (2005) 0.75
The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg (2005) 0.75
Superior mesenteric artery syndrome presenting with pneumoperitoneum and pneumomediastinum. Am Surg (2013) 0.75
Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group. Am Surg (2017) 0.75
Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability. Ann Surg (2015) 0.75
Risk of thyroid cancer in Hispanics: a cohort study. Am Surg (2013) 0.75